These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34840747)

  • 1. Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers.
    Starnoni M; Pappalardo M; Spinella A; Testoni S; Lattanzi M; Feminò R; De Santis G; Salvarani C; Giuggioli D
    Ann Med Surg (Lond); 2021 Nov; 71():102984. PubMed ID: 34840747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
    Silva C; Solanki KK; White DHN
    Rheumatol Immunol Res; 2022 Jun; 3(2):84-89. PubMed ID: 36465326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.
    Young A; Namas R; Dodge C; Khanna D
    Curr Treatm Opt Rheumatol; 2016 Sep; 2(3):252-269. PubMed ID: 28018840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches.
    Volkmann ER; Furst DE
    Rheum Dis Clin North Am; 2015 Aug; 41(3):399-417. PubMed ID: 26210126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis: Current concepts of skin and systemic manifestations.
    Pearson DR; Werth VP; Pappas-Taffer L
    Clin Dermatol; 2018; 36(4):459-474. PubMed ID: 30047430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study.
    Pignatti M; Spinella A; Cocchiara E; Boscaini G; Lusetti IL; Citriniti G; Lumetti F; Setti G; Dominici M; Salvarani C; De Santis G; Giuggioli D
    Aesthetic Plast Surg; 2020 Oct; 44(5):1820-1832. PubMed ID: 32632623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of botulinum toxin type A injection for Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis.
    Jokar MH; Baghbani B; Geraylow KR; Shariati J; Mehrad-Majd H; Mirfeizi Z; Hashemzadeh K
    Reumatologia; 2022; 60(6):392-398. PubMed ID: 36683833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature.
    Giuggioli D; Manfredi A; Lumetti F; Colaci M; Ferri C
    Autoimmun Rev; 2018 Feb; 17(2):155-164. PubMed ID: 29196241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients.
    Silva I; Almeida J; Vasconcelos C
    Autoimmun Rev; 2015 Feb; 14(2):140-52. PubMed ID: 25449678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020.
    Maltez N; Hughes M; Brown E; Hickey V; Park H; Shea B; Herrick AL; Pauling JD; Proudman S; Merkel PA
    Semin Arthritis Rheum; 2021 Jun; 51(3):640-643. PubMed ID: 33947582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.
    Kumar U; Sankalp G; Sreenivas V; Kaur S; Misra D
    Rheumatol Int; 2013 Apr; 33(4):1047-52. PubMed ID: 22833239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.
    Motegi S; Yamada K; Toki S; Uchiyama A; Kubota Y; Nakamura T; Ishikawa O
    J Dermatol; 2016 Jan; 43(1):56-62. PubMed ID: 26173902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
    Bellis R; Francès C; Barète S; Senet P
    Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis.
    Hughes M; Huang S; Pauling JD; Sabbagh M; Khanna D
    Clin Rheumatol; 2022 Oct; 41(10):3049-3054. PubMed ID: 35583625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Galluccio F; Matucci-Cerinic M
    Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.